@article{article, title = {{Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}}, publisher = {{Adis}}, url = {{http://eprints.whiterose.ac.uk/108856/ http://www.readcube.com/articles/10.1007/s40273-016-0457-1?author_access_token=rbXYVuOBuR58SeGgHskhpve4RwlQNchNByi7wbcMAY6MEWC31o0d4h78u4fova25uJYul-_IVvaUf5Ko-2nnX0OFXNZYPoqEMa_zYnT2yqE2DtYjUUNVTAI-S }}, year = {{2016}}, month = {{10}}, author = {{Kearns B and Pandor A and Stevenson M and Hamilton J and Chambers D and Clowes M and Graham J and Kumar MS}}, doi = {{10.1007/s40273-016-0457-1}}, volume = {{35}}, journal = {{PharmacoEconomics}}, issue = {{4}}, pages = {{415-424}}, note = {{Accessed on 2025/05/26}}}